Camila Freire Brant
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Camila Freire Brant has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Augusto de Faria Almeida
Alfenas Federal University, Brazil
2 shared publications - Letícia da Costa Siqueira
Federal University of Alfenas
2 shared publications - Suzane Cristina Pigossi
Federal University of Uberlândia, Brazil
2 shared publications - Alessandro Antônio Costa Pereira
Federal University of Alfenas
1 shared publication - Annette Wiegand
Department of Preventive Dentistry, Periodontology and Cariology University Medical Centre Göttingen Göttingen Germany
1 shared publication - Bruna Cardoso
Faculdade de Odontologia de Alfenas, Universidade Federal de Alfenas- UNIFAL-MG, Alfenas - MG, Brasil
1 shared publication
Latest Publications
- Open Access
- 14 October 2026
- Published by Universidade Estadual de Campinas in Brazilian Journal of Oral Sciences
- Vol. 25, e269016
Oral paracoccidioidomycosis
Paracoccidioidomycosis (PCM) is a severe systemic fungal infection of significant clinical importance due to its high incidence and mortality. Its geographical distribution is heterogeneous, with regions of both high and low endemicity, depending on the climate and agricultural conditions. Aim: The objective of this study was to evaluate the prevalence of PCM in the South of Minas Gerais State and identify the population at most risk for developing and progressing the disease. Methods: Thus, we performed a retrospective analysis of histopathological reports from the Oral Pathology Laboratory at Federal University of Alfenas, from 1999 to 2019. Results: The results revealed that 86 patients were diagnosed with PCM during the analyzed period. Of these, 6.98% were excluded due to incomplete histopathological request forms. Among the 80 patients analyzed, a higher prevalence was observed in males (82.50%) and leucodermic individuals (60.0%), with PCM being the most frequent diagnostic hypothesis (66.25%). The average age of female patients was higher than that of male ones. A predominance of multiple lesions was observed, regardless of the patients’ sex. Conclusions: Hence, this study highlights the high prevalence of PCM in the South of Minas Gerais, emphasizing the need for education and monitoring of both the population and healthcare professionals in this endemic region. Early recognition and proper treatment are essential to prevent PCM-related sequelae and death. Additionally, the need for investment in scientific research on new therapeutic options becomes evident.
- 14 October 2026
- Published by Universidade Estadual de Campinas in Brazilian Journal of Oral Sciences
- Vol. 25, e269016
Open AccessOral paracoccidioidomycosis
Paracoccidioidomycosis (PCM) is a severe systemic fungal infection of significant clinical importance due to its high incidence and mortality. Its geographical distribution is heterogeneous, with regions of both high and low endemicity, depending on the climate and agricultural conditions. Aim: The objective of this study was to evaluate the prevalence of PCM in the South of Minas Gerais State and identify the population at most risk for developing and progressing the disease. Methods: Thus, we performed a retrospective analysis of histopathological reports from the Oral Pathology Laboratory at Federal University of Alfenas, from 1999 to 2019. Results: The results revealed that 86 patients were diagnosed with PCM during the analyzed period. Of these, 6.98% were excluded due to incomplete histopathological request forms. Among the 80 patients analyzed, a higher prevalence was observed in males (82.50%) and leucodermic individuals (60.0%), with PCM being the most frequent diagnostic hypothesis (66.25%). The average age of female patients was higher than that of male ones. A predominance of multiple lesions was observed, regardless of the patients’ sex. Conclusions: Hence, this study highlights the high prevalence of PCM in the South of Minas Gerais, emphasizing the need for education and monitoring of both the population and healthcare professionals in this endemic region. Early recognition and proper treatment are essential to prevent PCM-related sequelae and death. Additionally, the need for investment in scientific research on new therapeutic options becomes evident.
- Open Access
- 24 June 2026
- Published by Elsevier in Journal of Dentistry
- Vol. 174, 106859
Is erosive tooth wear a truly non-bacterial condition? A scoping review
- 24 June 2026
- Published by Elsevier in Journal of Dentistry
- Vol. 174, 106859
Open AccessIs erosive tooth wear a truly non-bacterial condition? A scoping review
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Pesquisa Brasileira em Odontopediatria e Clínica Integrada
- Vol. 26
Effects of Cannabinoids Use in Temporomandibular Disorders: A Scoping Review
Objective: To assess the effects of cannabis and its synthetically derived products on temporomandibular disorders (TMD) treatment and explore the potential mechanisms underlying these effects in various TMD nociception models. Material and Methods: Electronic searches in five databases were conducted for publications up to August 2024. Clinical and animal studies about the use of cannabinoids for TMD-related pain control were included. Letters to the editor, conference proceedings, protocol articles, historical reviews, in vitro studies, and unpublished articles were excluded. Results: A total of 2,708 unique citations were found. Following the screening, 31 studies were evaluated as full-text copies, and 13 (nine pre-clinical, two observational, and two interventional studies) were included. The pre-clinical studies demonstrated that cannabinoid compounds effectively reduce nociceptive behavior in the temporomandibular joints (TMJ) and masseter muscle using different animal models. Moreover, all the included studies using formalin-induced TMJ nociception reported that cannabinoid agonist-induced antinociception in the TMJ region was mediated by the central activation of CB1 but not CB2 receptors. The observational and interventional studies reported pain reduction, improvement in function, and better health quality with cannabis use. Furthermore, the use of cannabis for chronic pain appears to be an effective alternative to the use of opioids and other pain control drugs associated with unwanted side effects. Conclusion: The use of cannabis and its synthetically derived products seems to be effective in reducing nociceptive behavior in TMJ and masseter muscle. However, further clinical and mechanistic studies are necessary to thoroughly investigate the therapeutic potential of cannabinoid compounds in TMD.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Pesquisa Brasileira em Odontopediatria e Clínica Integrada
- Vol. 26
Open AccessEffects of Cannabinoids Use in Temporomandibular Disorders: A Scoping Review
Objective: To assess the effects of cannabis and its synthetically derived products on temporomandibular disorders (TMD) treatment and explore the potential mechanisms underlying these effects in various TMD nociception models. Material and Methods: Electronic searches in five databases were conducted for publications up to August 2024. Clinical and animal studies about the use of cannabinoids for TMD-related pain control were included. Letters to the editor, conference proceedings, protocol articles, historical reviews, in vitro studies, and unpublished articles were excluded. Results: A total of 2,708 unique citations were found. Following the screening, 31 studies were evaluated as full-text copies, and 13 (nine pre-clinical, two observational, and two interventional studies) were included. The pre-clinical studies demonstrated that cannabinoid compounds effectively reduce nociceptive behavior in the temporomandibular joints (TMJ) and masseter muscle using different animal models. Moreover, all the included studies using formalin-induced TMJ nociception reported that cannabinoid agonist-induced antinociception in the TMJ region was mediated by the central activation of CB1 but not CB2 receptors. The observational and interventional studies reported pain reduction, improvement in function, and better health quality with cannabis use. Furthermore, the use of cannabis for chronic pain appears to be an effective alternative to the use of opioids and other pain control drugs associated with unwanted side effects. Conclusion: The use of cannabis and its synthetically derived products seems to be effective in reducing nociceptive behavior in TMJ and masseter muscle. However, further clinical and mechanistic studies are necessary to thoroughly investigate the therapeutic potential of cannabinoid compounds in TMD.
- Open Access
- 31 January 2024
- Published by Archives of Health Investigation in ARCHIVES OF HEALTH INVESTIGATION
- Vol. 13 (1) , 38-47
Dispositivos Orais para o Tratamento da Apneia do Sono: Revisão de Literatura
Introdução: A Apneia Obstrutiva do Sono (AOS) é um distúrbio caracterizado por colapso intermitente das vias aéreas superiores que afeta cerca de 30% da população adulta e pode ser tratada por meio de dispositivos orais. Objetivo: Apresentar uma revisão narrativa da literatura sobre o uso e eficácia dos dispositivos orais para o tratamento da AOS. Material e método: Os termos “Obstructive Sleep Apnea”, “Treatment”, “Mandibular Advancement”, “Oral Appliances” foram pesquisados nas bases de dados Pubmed/Medline e Google Schoolar no período compreendido entre 2009 e 2020 e 20 artigos foram selecionados para compor a revisão de literatura. Resultados: Um tratamento bastante discutido para AOS é a terapia com pressão positiva contínua nas vias aéreas; porém, essa terapia possui falhas devido à intolerância e a baixa adesão pelos pacientes. Assim, dispositivos orais são discutidos como principal alternativa a este tratamento. Os aparelhos mais comumente usados são os dispositivos de avanço mandibular e os retentores, controladores ou estabilizadores de língua por serem considerados eficazes e seguros para o tratamento da AOS já que melhoram os parâmetros polissonográficos, como o índice de apneia-hipopneia, reduzindo de forma significativa o ronco e a sonolência diurna excessiva. Embora os efeitos colaterais existam, esses dispositivos também são capazes de causar efeito positivo na saturação mínima de oxigênio e, de forma geral, são bem aceitos pelos pacientes. Conclusão: O Cirurgião-Dentista tem ganhado um papel muito importante ao reconhecer os distúrbios do sono, encaminhar seus pacientes à um médico especializado e, quando indicado, oferecer o tratamento com os dispositivos orais.
- 31 January 2024
- Published by Archives of Health Investigation in ARCHIVES OF HEALTH INVESTIGATION
- Vol. 13 (1) , 38-47
Open AccessDispositivos Orais para o Tratamento da Apneia do Sono: Revisão de Literatura
Introdução: A Apneia Obstrutiva do Sono (AOS) é um distúrbio caracterizado por colapso intermitente das vias aéreas superiores que afeta cerca de 30% da população adulta e pode ser tratada por meio de dispositivos orais. Objetivo: Apresentar uma revisão narrativa da literatura sobre o uso e eficácia dos dispositivos orais para o tratamento da AOS. Material e método: Os termos “Obstructive Sleep Apnea”, “Treatment”, “Mandibular Advancement”, “Oral Appliances” foram pesquisados nas bases de dados Pubmed/Medline e Google Schoolar no período compreendido entre 2009 e 2020 e 20 artigos foram selecionados para compor a revisão de literatura. Resultados: Um tratamento bastante discutido para AOS é a terapia com pressão positiva contínua nas vias aéreas; porém, essa terapia possui falhas devido à intolerância e a baixa adesão pelos pacientes. Assim, dispositivos orais são discutidos como principal alternativa a este tratamento. Os aparelhos mais comumente usados são os dispositivos de avanço mandibular e os retentores, controladores ou estabilizadores de língua por serem considerados eficazes e seguros para o tratamento da AOS já que melhoram os parâmetros polissonográficos, como o índice de apneia-hipopneia, reduzindo de forma significativa o ronco e a sonolência diurna excessiva. Embora os efeitos colaterais existam, esses dispositivos também são capazes de causar efeito positivo na saturação mínima de oxigênio e, de forma geral, são bem aceitos pelos pacientes. Conclusão: O Cirurgião-Dentista tem ganhado um papel muito importante ao reconhecer os distúrbios do sono, encaminhar seus pacientes à um médico especializado e, quando indicado, oferecer o tratamento com os dispositivos orais.